Method for treating a neurodegenerative disease by administering an anti-cellular prion protein (PrPc) antibody
US12110336B2 · kind B2 · utility
0Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2020 |
| Grant date | Oct 8, 2024 |
| Priority date | — |
| Expiry date | Mar 21, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure provides antibodies and antigen-binding fragments capable of binding PrPC. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.